OraSure Boardroom Battle: Hedge Funds Clash Over Rapid Tests

Hedge fund Altai Capital is preparing for a boardroom battle at OraSure Technologies, the COVID test maker, after its stock price plummeted. Frustrated by a rejected buyout offer and unmet promises, Altai, along with another hedge fund manager, seeks to shake up OraSure's leadership by nominating new directors at next year's shareholder meeting. Will fresh voices revitalize the company and reverse its stock's decline amidst fierce competition from industry giants? Hosted on Acast. See acast.com/privacy for more information.